ROCKVILLE, Md. -- (BUSINESS WIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company’s senior management team will participate in the following investor conferences in June 2014:
For the Jefferies and JMP Securities conferences, the company will be webcasting the formal portion of its participation, which may include a discussion of the company's recent business developments as well as its current financial results and financial guidance for the current year and latest quarterly period. The webcasts will be available both live and by replay, accessible from the Emergent website www.emergentbiosolutions.com under “Investors.”
For the Janney Capital Markets conference, the company will only be participating in one-on-one meetings. The conference format does not include formal presentations.
About Emergent BioSolutions Inc.
Emergent BioSolutions is a specialty biopharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Additional information about the company may be found at www.emergentbiosolutions.com.
Follow us on twitter: @emergentbiosolu.